zum Inhalt

Digitale Medizin

-
Elisabeth-Herz-Kremenak-Saal
Plenary / Panel
in englischer Sprache

Rasante Fortschritte in der Technologie haben in der Medizin ein enormes Spektrum an diagnostischen Methoden geschaffen. Gezielte und effiziente Prävention und Therapie werden möglich. Der Nutzen von „Big Data“ in der Medizin ist groß, zugleich sorgt der Umgang mit sensiblen Daten für große Unsicherheit. ExpertInnen geben Einblick in den aktuellen Stand der Technologie, das gesellschaftliche Potenzial und die kontroversen Perspektiven.

Vortragende

David M. Levy Professor of Neurology and Director, Center for Human Experimental Therapeutics, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY Abstract
Telehealth, the use of telecommunications to provide care to individuals at a distance, is growing rapidly. Three trends are emerging. The first is the driving force for telehealth shifting from solely increasing access to now providing convenience and in the future reducing cost. The second is the historical application to acute conditions (like trauma and stroke) to episodic conditions (like sinusitis) to chronic conditions (like Parkinson disease). The third, and perhaps most important, is the migration of care provision from remote hospitals and satellite clinics to the home and in the future mobile devices. The discussion will provide examples of these trends, highlight implications, and speculate on the timing of these trends.
President of the EuroRec Institute; President of i~HD; Professor of Health Informatics, UCL; Visiting Professor, University of Gent Abstract
The concept of the "Digital Patient" can be considered as the consolidated information that is known about an individual that has the potential to impact on their health, health care, and decision-making. This is not at all limited to information that is quantified (numeric) or to information that has been captured using new generation wearables and sensors. The Digital Patient concept spans information that is conventionally captured by clinicians in health records, by patients in personal health records and of course information captured from mobile devices. It includes information relevant to the patient derived from clinical guidelines and care pathways. Genetic information, metabolic profiles and micro-biome profiles are of increasing importance as bio-markers are being discovered that help to stratify patients into risk or treatment groups. This information space should include the algorithms and mathematical models that simulate or predict future risks and prognoses, and which help to optimise treatment decisions. It potentially includes information about others, and from others, such as family members and social networks. This totality of information is what guides healthcare professionals and the patient himself or herself, to make optimal health, wellness and lifestyle decisions. These decisions include caring for existing diseases as well as strategies for preventing those that have not yet arisen.
It is increasingly important for us to harness the opportunities from mathematical modelling and from biomarker profiling of patients, and to partner patients in their own coproduction of health, if we are to tackle the challenge of an ageing society and a proliferation of long-term conditions. We need to use fine-grained information derived from populations of patients to evidence how best to redesign health services, and to reuse that information for research, to underpin the discovery of innovative and safe treatments.
The concept of the Digital Patient is therefore an exciting opportunity for us to improve health systems, accelerate research, and to personalise the way health care is delivered and guidance is provided to patients.
Vice President, European Forum Alpbach; Professor and Chair, Department of Ophthalmology, Medical University of Vienna
Charles A. Dewey Professor and Senior Vice President for Health Sciences, Chief Executive Officer, and Dean of the School of Medicine and Dentistry, University of Rochester Medical Center, University of Rochester Abstract
Health care delivery in the United States is undergoing a transformation from fee-for-service to a value-based system, involving the development of large health care networks that are paid a set fee for taking care of a population. This transformation necessitates that every effort be made to provide the highest quality and most cost-efficient health care. A cornerstone of this transformation is the widespread adaptation of the electronic medical record (EMR); those systems that can utilize technology to take best advantage of the EMR are likely to have the best chances of thriving in the new health care environment. In addition, those systems that can exploit technology to maximize patient engagement will be the most successful. This presentation will discuss approaches being employed at the University of Rochester Medical Center to exploit technology to enhance quality, improve patient engagement, and provide cost-efficient care throughout upstate New York. It will discuss PROMIS (Patient Reported Outcomes Measurement Information System), a novel approach to better involve patients in their health care and to reduce health care costs. This approach involves the use of an ipad-based questionnaire that allows health care providers to regularly assess a patient's physical, mental and social health and can identify issues far more rapidly than conventional testing. One of the challenges in developing large health care networks is the ability to provide specialty services to rural areas. This presentation will introduce the concept of "telementoring," in distinction to telemedicine. Project ECHO (Extension for Community Healthcare Outcomes) uses multipoint videoconferencing and the internet to significantly increase specialty care for common complex conditions by linking expert specialist teams at an academic "hub" with front-line clinicians ("spokes") in local communities.
Senior Vice President for Research and Dean, Hajim School of Engineering and Applied Sciences, University of Rochester; Director, Minerals Technologies Incorporated; Rochester Chair
Vice Rector for Research and Innovation, Medical University of Vienna; Member of the Steering Committee, European Forum Alpbach, Vienna Chair

MD MBA E. Ray DORSEY

David M. Levy Professor of Neurology and Director, Center for Human Experimental Therapeutics, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY

1993 Intern, U.S. Health Care Financing Administration (now the Centers for Medicare & Medicaid Services), Washington, DC
1994 Biological sciences, Stanford University, Stanford, CA
1995 Intern, Robert Wood Johnson Foundation, Princeton, NJ
1998 Investment banking summer associate, Health Care Group, Credit Suisse First Boston, Chicago, IL
1999 MD University of Pennsylvania School of Medicine, Philadelphia, PA
1999 MBA Health care management, The Wharton School, University of Pennsylvania, Philadelphia, PA
1999-2001 Associate, McKinsey & Company, Chicago, IL
2001-2002 Medicine Intern, Evanston Hospital, Evanston Northwestern Healthcare, Evanston, IL
2002-2005 Neurology Resident, University of Pennsylvania Medical Center, Philadelphia, PA
2005-2007 Fellow in movement disorders and experimental therapeutics, University of Rochester, Rochester, NY
2005-2006 Instructor, Department of Neurology, University of Rochester, Rochester, NY
2006-2007 Senior Instructor, Department of Neurology, University of Rochester, Rochester, NY
2007-2010 Assistant professor, Department of Neurology, University of Rochester, Rochester, NY
since 2010 Director of Movement Disorders Division, Johns Hopkins University, Baltimore, MD

Ph.D. FRCGP Dipak KALRA

President of the EuroRec Institute; President of i~HD; Professor of Health Informatics, UCL; Visiting Professor, University of Gent

1982-1988 Hospital doctor and trainee General Practitioner, London
1988-1995 General Practitioner, London
1995-2000 Clinical Lecturer, University College London
2000-2009 Clinical Senior Lecturer, University College London
since 2009 Professor of Health Informatics, University College London
since 2012 President, the European Institute for Health Records (EuroRec)
since 2014 Visiting Professor, University of Gent
since 2015 President, the European institute for Innovation through Health Data (i~HD)

Dr. Ursula SCHMIDT-ERFURTH

Vice President, European Forum Alpbach; Professor and Chair, Department of Ophthalmology, Medical University of Vienna

1979-1986 Medical School, Ludwig-Maximilians-University, Munich
1986 Doctoral thesis, University Eye Hospital, Munich
1986 Internal rotation in Ophthalmic Pathology Howe Laboratory, Harvard Medical School, Mass. Eye and Ear Infirmary, Boston, MA
1986-1987 Research Fellow, Institute of Immunology, Ludwig-Maximilians-University, Munich
1987-1990 Resident in Ophthalmology, University Eye Hospital, Munich
1990-1992 Research Fellow in Photomedicine, Wellman Laboratories, Mass. General Hospital, Harvard Medical School, Boston, MA
1991-1992 Research Fellow in Ophthalmology, Retina-Department, Massachusetts Ear Infirmary, Harvard Medical School, Boston, MA
1992-1993 Clinical Fellow in Medical Retina, University Eye Hospital, Medical University of Lübeck
1992-2004 Research Associate, Medical Laser Center, University of Lübeck, Germany
1993-1995 Instructor in Ophthalmology, University Eye Hospital Lübeck
1996-1999 Assistant Professor in Ophthalmology, University Eye Hospital Lübeck
2000-2004 Professor in Ophthalmology
since 2004 Appointment at the University of Vienna, Professor and Chair of Ophthalmology
2008 Visiting Professorship: Mc Gill University / Montreal / Canada
since 2009 Lecturer, ESASO - European School for Advanced Studies in Ophthalmology, Lugano
since 2009 Lecturer, PhD-Program at CeMM, Center for Molecular Medicine, Academy of Sciences, Vienna
since 2010 Elected member of the Senate, MUW - Medical University of Vienna

MD Mark B. TAUBMAN

Charles A. Dewey Professor and Senior Vice President for Health Sciences, Chief Executive Officer, and Dean of the School of Medicine and Dentistry, University of Rochester Medical Center, University of Rochester

 BA in Biochemistry, Columbia University
 MA in Biochemistry, New York University School of Medicine
 5 Years Fellowship, Brigham & Women's Hospital, Harvard Medical School
 Professor, Medicine, Mount Sinai School of Medicine, New York
 Professor, Chairman, University of Rochester School of Medicine and Dentistry

Ph.D. M.Sc. B.Sc. Robert CLARK

Senior Vice President for Research and Dean, Hajim School of Engineering and Applied Sciences, University of Rochester; Director, Minerals Technologies Incorporated; Rochester

1992 Ph.D., Mechanical Engineering at Virginia Polytechnic Institute and State University
1996-2001 Director, Center for Applied Control, Duke University, Durham, North Carolina
1998-2000 Associate Professor, Duke University, Durham, North Carolina
1999-2000 Chief Technology Officer, Imeron, Cary, North Carolina
2000-2001 Professor, Duke University
2001-2003 Jeffrey N. Vinik Professor, Duke University
2001-2007 Director, Center for Biologically Inspired Materials and Material Systems, Duke University
2001-2003 Senior Associate Dean for Research, Pratt School of Engineering, Duke University
since 2003 Secondary Appointment, Department of Biomedical Engineering
since 2003 Thomas Lord Professor of Engineering, Duke University
2003-2007 Senior Associate Dean, Pratt School of Engineering, Duke University
2007 Chair, Mechanical Engineering and Materials Science, Duke University
2007-2008 Dean, Pratt School of Engineering, Duke University
since 2008 Professor, Hajim School of Engineering and Applied Sciences, University of Rochester
2008-2016 Dean, Hajim School of Engineering and Applied Sciences, University of Rochester
since 2010 Director, Minerals Technologies Incorporated (MTX)
2012-2016 Senior Vice President for Research, University of Rochester
since 2016 Provost and Senior Vice President for Research, University of Rochester

DI Dr. Michaela FRITZ

Vice Rector for Research and Innovation, Medical University of Vienna; Member of the Steering Committee, European Forum Alpbach, Vienna

1989-1994 Master studies, Department of Materials Science, ETH Zurich
1994-1995 Diploma thesis, Washington Research Centre, W. R. Grace, Columbia, Maryland, MD
1995-1998 Research assistant; Teaching assistant, Laboratory for Surface Science and Technology, ETH Zurich
1996-2000 Ph.D. studies, Department of Materials Science, ETH Zurich
2000-2001 Ph.D. scientist, Department of Chemical Engineering, University of California, Berkeley, CA
2001-2004 Business development, Bioscience, Infineon Technologies AG, Munich
2005-2010 Head, LISA - Life Sciences Austria, Technology & Innovation, Austria Wirtschaftsservice GmbH, Vienna
2006-2010 Managing Director, LISA VR, Life Science Austria Vienna Region, Vienna
2010-2015 Head, Department Health and Environment, AIT - Austrian Institute of Technology, Vienna
2012-2016 President, AAL Austria, Vienna
since 2015 Vice-Rector, Research and Innovation, Medical University Vienna
since 2015 Member, Scientific Advisory Committee, Joanneum Research, Vienna
since 2018 Vice President, European Forum Alpbach, Vienna

Technologiegespräche

Timetable einblenden

25.08.2016

13:00 - 13:10EröffnungPlenary
13:10 - 14:15FTI-TalkPlenary
14:30 - 14:50Von Österreich ins Silicon Valley - Cyber-Sicherheit als globaler FaktorPlenary
14:50 - 16:10Kybernetik in modernen Energie- und ProduktionssystemenPlenary
16:30 - 17:45Komplexität und die neue AufklärungPlenary
20:00 - 20:15Best of Art and ScienceCulture
20:15 - 21:15Tickets to Berlin: Falling Walls Lab Austria and Alpbach Summer School on EntrepreneurshipPlenary
21:30 - 23:30AbendempfangSocial
21:30 - 23:00KarriereloungeSocial

26.08.2016

09:00 - 10:30Digitale MedizinPlenary
09:00 - 18:00Junior Alpbach - Wissenschaft und Technologie für junge MenschenBreakout
09:00 - 15:00Ö1 Kinderuni Alpbach - Wissenschaft und Technologie für KinderBreakout
10:30 - 12:30Cross-sektorale Kooperationen von ClusternPartner
11:00 - 12:30Personalisierte KrebsmedizinPlenary
12:30 - 13:00Imbiss für die TeilnehmerInnen der Breakout SessionsSocial
13:00 - 18:00Breakout Session 01: Innovation by Making: Paradigmenwechsel und neue InnovationskulturenBreakout
13:00 - 18:00Breakout Session 02: Silicon Austria: Ein Game-Changer für den österreichischen Hochtechnologiestandort?Breakout
13:00 - 18:00Breakout Session 03: Zukunft erfinden: Innovationsprozesse neu gestaltenBreakout
13:00 - 18:00Breakout Session 04: Der Zyklus der Innovation und seine ÖkologieBreakout
13:00 - 18:00Breakout Session 05: Zukunftstechnologie LeichtbauBreakout
13:00 - 18:00Breakout Session 06: Der Blick ins Ungewisse und die Verschiebung des HorizontsBreakout
13:00 - 18:00Breakout Session 07: Radikale Innovationen: Mehr Mut zum RisikoBreakout
13:00 - 18:00Breakout Session 08: Technologierezeption von neuen Bildungswerbenden - ein Plädoyer für transkulturelle Kompetenz als neue AufklärungBreakout
13:00 - 18:00Breakout Session 09: Cyber Security: Ein GrundrechtBreakout
13:00 - 18:00Breakout Session 10: Open Access & Open Innovation als Instrumente einer neuen Aufklärung?Breakout
13:00 - 18:00Breakout Session 11: Robotik - Realitäten und ZukunftsperspektivenBreakout
13:00 - 18:00Breakout Session 12: Energiewende - die Macht der KonsumentenBreakout
13:00 - 18:00Breakout Session 13: Standortfaktor VersorgungssicherheitBreakout
19:00 - 20:30Innovations-Marathon: Ideen auf Bestellung - 24 Stunden nonstopPlenary

27.08.2016

09:00 - 10:30Art Meets Science and Technology - Wege einer neuen AufklärungPlenary
10:45 - 11:45Open Innovation: Neue Aufklärung? Partizipation - Demokratisierung - neue LösungenPlenary
12:15 - 13:30Die ETH Zürich zu Gast bei den TechnologiegesprächenPlenary
13:30 - 14:00Imbiss zum Abschluss der VeranstaltungSocial